ARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis – DSMB Recommendation Anticipated in August 2017
June 20, 2017 08:30 ET
|
ARCA Biopharma, Inc.
GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial Fibrillation Gencaro Development Program Previously Granted Fast Track Designation by U.S. FDA ...
ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
May 15, 2017 08:30 ET
|
ARCA Biopharma, Inc.
WESTMINSTER, Colo., May 15, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
UCHealth is Colorado's first health system to implant new device to prevent strokes
February 23, 2016 11:08 ET
|
UCHealth
AURORA, Colo., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Heart specialists at UCHealth's Medical Center of the Rockies and University of Colorado Hospital are the first in the region to implant a new device...
Survey Reveals How AFib Patients Age 65+ View Risks, Diagnosis, and Treatment
February 24, 2015 09:08 ET
|
Alliance for Aging Research
WASHINGTON, DC,, Feb. 24, 2015 (GLOBE NEWSWIRE) -- A survey released by the nonprofit Alliance for Aging Research of more than 500 patients age 65 and over with atrial fibrillation (AFib) reveals...
Top U.S. Heart Treatment Centers, Patient Group, Form Alliance to Improve Irregular Heartbeat Care
June 18, 2014 06:00 ET
|
National Alliance of Integrated AFib Centers
NORFOLK, VA--(Marketwired - Jun 18, 2014) - National Alliance of Integrated AFib Centers
Overview
Top U.S. heart centers implement a collaborative,...
MRI Interventions' ClearTrace System to be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
February 27, 2014 08:00 ET
|
ClearPoint Neuro, Inc.
IRVINE, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace® system for MRI-guided, catheter-based cardiac procedures will be...
MRI Interventions and Siemens Enter Into Agreement to Commercialize Next Generation Software Platform to Enable MRI-Guided, Catheter-Based Procedures
February 24, 2014 08:00 ET
|
ClearPoint Neuro, Inc.
IRVINE, Calif., Feb. 24, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software...
American Heart Association/American Stroke Association Survey Reveals Positive Results on Patient Perception of Risks Associated Between Atrial Fibrillation and Stroke
September 05, 2012 08:00 ET
|
American Heart Association
DALLAS, Sept. 5, 2012 (GLOBE NEWSWIRE) -- Findings from a recent American Heart Association/American Stroke Association survey noted the increased awareness in patients suffering from atrial...
New Program to Improve In-Hospital Atrial Fibrillation Care
June 25, 2012 11:44 ET
|
American Heart Association
News Release Highlights:
The American Heart Association will expand its Get With The Guidelines® quality improvement program to improve the care of patients hospitalized with atrial...
Stroke Risk High When Anti-Clotting Drugs Stopped
April 25, 2012 13:00 ET
|
American Heart Association
Study Highlights:
Patients with irregular heartbeats who take anti-clotting medications are at high risk of stroke or blood clot whenever the drugs are stopped.
The risks are similar...